Live attenuated influenza vaccine (Fluenz Tetra®) : patient group direction (PGD) template
- Public Health England
- Part of:
- Immunisation patient group direction (PGD) templates
- 25 August 2015
- Last updated:
- 30 June 2016, see all updates
PGD template to support the national influenza immunisation programme
Ref: PHE publications gateway number: 2015271 MS Word Document, 452KB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This patient group direction (PGD) template is to support the influenza immunisation programme. It is valid from 1 September 2016 to 31 March 2017.
This PGD template requires further authorisation by an appropriate authorising person, relating to the class of person by whom product is to be supplied, in accordance with the Human Medicines Regulations 2012 (HMR). This may be a clinical governance or patient safety lead, who has designated responsibility for signing PGDs on behalf of the authorising body. The PGD is not legal or valid without signed authorisation in accordance with HMR 2012 schedule 16 part 2
Adoption and governance of the use of this PGD is the responsibility of the authorising organisation and provider.
Provider organisations, health professionals and immunisation practitioners should check they are working to the current PGD versions and only work to documents authorised in accordance with HMR 2012 schedule 16 part 2.
Published: 25 August 2015
Updated: 30 June 2016
- Updated PGD template for the 2016 to 2017 flu season.
- Updated PGD to allow the provision of both presentations of live attenuated influenza vaccine which will be supplied for the 2015/16 season.
- First published.